News and Announcements
HashChing Announces New Partnership with Titleexchange
- Published July 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
HashChing is Australia’s first online home loan marketplace allowing borrowers to get connected to local mortgage brokers who have access to negotiated rates that lenders don’t advertise anywhere. The company has recently announced a new partnership for digital conveyancing.
KEY TAKEAWAYS:
- HashChing is now offering the services of electronic conveyancing marketplace with Titleexchange.
- The integration of both companies allows users to access fixed-prices without having to go offline to provide identification or personal data.
- Conveyancing packages accessed through HashChing are 10% cheaper than the standalone Titlexchange prices.
- The partnership follows HashChing’s deal with CGU Insurance in March offering discounted home insurance.
- The company has already processed more than $7 billion worth of loan applications from over 14,000 applicants.
HashChings chief information Officer, Atul Narang said:
“We connect users with a local conveyancer the same way we connect them with a local mortgage broker, since the whole procedure is completed online, it minimises the manual processes and paperwork associated with property exchange.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
